First Header Logo Second Header Logo

Connection

David Kline to Opioid-Related Disorders

This is a "connection" page, showing publications David Kline has written about Opioid-Related Disorders.
Connection Strength

1.397
  1. Kline D, Hepler S, Bonny A, McKnight E. A joint spatial model of opioid-associated deaths and treatment admissions in Ohio. Ann Epidemiol. 2019 05; 33:19-23.
    View in: PubMed
    Score: 0.559
  2. Murphy E, Kline D, McKnight E, Bonny A, Miller WC, Waller L, Hepler SA. Integrating data at multiple spatial scales to estimate the local burden of the opioid syndemic. Spat Spatiotemporal Epidemiol. 2025 Jun; 53:100720.
    View in: PubMed
    Score: 0.214
  3. Murphy E, Kline D, Egan KL, Lancaster KE, Miller WC, Waller LA, Hepler SA. Understanding the opioid syndemic in North Carolina: A novel approach to modeling and identifying factors. Biostatistics. 2024 Dec 31; 26(1).
    View in: PubMed
    Score: 0.209
  4. Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods. Epidemiology. 2023 Nov 01; 34(6):841-849.
    View in: PubMed
    Score: 0.192
  5. McKnight ER, Bonny AE, Lange HLH, Kline DM, Abdel-Rasoul M, Gay JR, Matson SC. Statewide opioid prescriptions and the prevalence of adolescent opioid misuse in Ohio. Am J Drug Alcohol Abuse. 2017 05; 43(3):299-305.
    View in: PubMed
    Score: 0.118
  6. Egan KL, Lewis B, Fields K, McMillian Iii J, Graves RL, Kline DM, Eldridge LA. Implementation of Medication Disposal Programs and Availability of Same-Day Naloxone at Community Pharmacies: Protocol for a Secret Shopper Caller Approach. JMIR Res Protoc. 2025 Jun 10; 14:e64344.
    View in: PubMed
    Score: 0.054
  7. Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.